Two companies using artificial intelligence to advance biotechnology and design new therapies are merging with a computational-engineering drug discovery enterprise. . . . → Read More: Computational Drug Discovery Company Acquires A.I. Businesses
|
|||||
       |
 Comments are closed  Finance  biomedical, biotechnology, Canada, chemistry, computer science, engineering, equity, genomics, investment, life sciences, mathematics, merger, pharmaceuticals, physical sciences, university 
Technology intelligence company CB Insights says this week that psychedelic therapies and services are generating little interest among venture investors this year, with only nine deals totaling $21 million. . . . → Read More: Infographic – Psychedelics Funding Coming Down Comments are closed Finance biomedical, biotechnology, chemistry, equity, investment, life sciences, pharmaceuticals, psychiatric, venture capital 
New research with lab animals shows gene-edited viruses can target and remove harmful E. coli bacteria from the gut, including strains usually resistant to antibiotics. . . . → Read More: Crispr Therapy Shown to Remove E. Coli in Gut One comment - (Comments are closed) New products biomedical, biotechnology, cancer, engineering, Europe, genomics, life sciences, pharmaceuticals, preclinical 
The first participant in a clinical trial received a dose of a psychedelic therapy, assessing the experimental compound in people with treatment resistant depression. . . . → Read More: Trial Underway Testing Psychedelic Drug for Depression One comment - (Comments are closed) New products biomedical, chemistry, clinical trials, life sciences, mathematics, pharmaceuticals, physical sciences, psychiatric, U.K. 
A genomic analysis of urine samples is shown to predict the most common form of bladder cancer years before symptoms appear. . . . → Read More: DNA Test Detects Early Bladder Cancer in Urine Comments are closed New products biomedical, biotechnology, cancer, clinical trials, engineering, genomics, life sciences, mathematics, medical device, NIH, physical sciences, university 
A new company that says it can stop disease-causing proteins from forming in cells began public operations today, and is raising $75 million in its first venture round. . . . → Read More: Biotech to Design Disease-Blocking Drugs, Gains $75M Comments are closed Finance, New products biomedical, biotechnology, chemistry, engineering, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, physical sciences, university, venture capital |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts